MBRX icon

Moleculin Biotech
MBRX

Overview Fund Trends Analyst Outlook Journalist POV

18 hedge funds and large institutions have $1.31M invested in Moleculin Biotech in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$381K
2
+$31.2K
3
+$29.8K
4
LPL Financial
LPL Financial
California
+$6.67K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.86K

Top Sellers

1
-$37K
2
-$523
3
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$824K
2
$203K
3
$103K
4
$62K
5
$35.4K
6
$31.2K
7
$29.8K
8
$9.47K
9
$5.14K
10
$3.88K
11
$1.27K
12
$406
13
$253
14
$97
15
$65
16
$48
17
$3